FDA Investigator Albinus M D'sa
Albinus M D'sa has conducted inspections on 4 sites in 2 countries as of 21 Apr 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
21 Apr 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Germany,
India
FDA Investigators that have inspected at least one site in common with Albinus M D'sa:
Alan P Kurtzberg,
Andrea A Branche,
Ann L Demarco,
Atul J Agrawal,
Carla J Lundi,
Dennis Cantellops Paite,
Dipesh K Shah,
Donna Mwilliams Hill, PhD,
Dr. Robert C Horan, MD,
Dr. S Nar Ali, PhD,
Jawaid Hamid,
John A Gonzalez,
Justine Tomasso,
Kara D Dobbin,
Karen K Moksnes,
Karen Takahashi,
Katherine Szestypalow,
Kenneth H Williams,
Kevin A Gonzalez,
Kham Phommachanh,
Pankaj H Amin,
Patsy J Domingo,
Peter E Baker,
Regina T Brown,
Sangeeta M Khurana, PhD,
Stephen D Brown,
Syed N Ali,
Yumi J Hiramine
Albinus M D'sa's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2003 | EIR | Morepen Laboratories Limited - EIR, 2004-02-10 |
November, 2003 | EIR | FDC Limited - EIR, 2004-01-22 |
November, 2003 | FDA 483 | FDC Limited - Form 483, 2003-11-12 |
October, 2003 | FDA 483 Response | Morepen Laboratories Limited - Form 483R, 2004-02-11 |
November, 2003 | FDA 483 Response | FDC Limited - Form 483R, 2003-12-31 |
November, 2003 | FDA 483 | Sun Pharmaceutical Industries Limited - Form 483, 2003-11-06 |
April, 2002 | FDA 483 Response | Siegfried PharmaChemikalien Minden GmbH - Form 483R, 2002-05-28 |
November, 2003 | FDA 483 Response | Sun Pharmaceutical Industries Limited - Form 483R, 2003-12-05 |
November, 2003 | EIR | Sun Pharmaceutical Industries Limited - EIR, 2004-01-22 |
April, 2002 | FDA 483 | Siegfried PharmaChemikalien Minden GmbH - Form 483, 2002-04-24 |
April, 2002 | EIR | Siegfried PharmaChemikalien Minden GmbH - EIR, 2002-04-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more